Objective In idiopathic inflammatory myopathies, anti-SSa/SSb and anti-Ro52 are
associated with interstitial lung disease (ILD), yet few studies have compared their …

Methods We performed a chart review of IIM patients diagnosed between January 2006 and
December 2020. All patients met either the 1975 Bohan and Peter or the European League …

Background Distinct clinical presentations of interstitial lung disease (ILD) with the myositis-
specific antibodies, including anti-synthetase antibodies, are well-recognized. However, the …

Objectives In the present study, we aimed to assess the prevalence and clinical significance
of anti-Ro52 antibodies in a cohort of patients with idiopathic inflammatory myopathy …

Background: Anti-Ro52 antibodies are detectable in multiple connective tissue diseases,
particularly Sjogren's syndrome, systemic lupus erythematosus, systemic sclerosis, as well …

Background: Idiopathic inflammatory myopathies (IIM) represent a group of systemic
autoimmune diseases with different clinical phenotypes and associated antibodies: myositis …

Background Myositis-specific autoantibodies (MSA) are increasingly recognized as
important diagnostic and prognostic markers in idiopathic inflammatory myopathies …

Objectives The purpose of this study was to determine the incidence of myositis-specific
autoantibodies (MSAs) in a cohort of Chinese patients with idiopathic inflammatory …

Objective. To characterize serum autoantibody profiles of patients with idiopathic
inflammatory myopathies (IIM) by searching for myositis-specific (MSA) and myositis …

The strongest predictive factor for the development of interstitial lung disease (ILD) in
myositis (IIM) patients is the presence of different antisynthetase antibodies. The aim of this …